Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Mendiola

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Ebiomedicine|October 11, 2016
G Protein-coupled Receptor Kinase 2 (GRK2) Promotes Breast Tumorigenesis Through a HDAC6-Pin1 AxisLaura Nogués, Clara Reglero, Verónica Rivas, et al.
Scientific Reports|April 25, 2018
Electrochemical affinity biosensors for fast detection of gene-specific methylations with no need for bisulfite and amplification treatmentsEloy Povedano, Eva Vargas, Víctor Ruiz-Valdepeñas Montiel, et al.
Virchows Archiv : an International Journal of Pathology|August 22, 2021
Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinomaIgnacio Ruz-Caracuel, Álvaro López-Janeiro, Victoria Heredia-Soto, et al.
Plos One|December 20, 2016
3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer PatientsTeodoro Vargas, Juan Moreno-Rubio, Jesús Herranz, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2016
Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine TumorsOmid Fotouhi, Hanna Kjellin, Catharina Larsson, et al.
Biomedicines|February 25, 2023
The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic AdenocarcinomaVictoria Heredia-Soto, Laura Gutiérrez-Sainz, Ismael Ghanem, et al.
Frontiers in Immunology|August 21, 2019
Anti-CXCR4 Antibody Combined With Activated and Expanded Natural Killer Cells for Sarcoma ImmunotherapyMaria Vela, David Bueno, Pablo González-Navarro, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 6, 2023
In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expressionAna Montero-Calle, Álvaro López-Janeiro, Marta L Mendes, et al.
Cancer Cell International|December 5, 2021
Eribulin activity in soft tissue sarcoma monolayer and three-dimensional cell line models: could the combination with other drugs improve its antitumoral effect?Javier Escudero, Victoria Heredia-Soto, Yinyin Wang, et al.
International Journal of Molecular Sciences|September 14, 2024
Cytokines and Pancreatic Ductal Adenocarcinoma: Exploring Their Relationship with Molecular Subtypes and PrognosisLaura Gutierrez-Sainz, Victoria Heredia-Soto, Ana Margarita Rodríguez-García, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Ebiomedicine|October 11, 2016
G Protein-coupled Receptor Kinase 2 (GRK2) Promotes Breast Tumorigenesis Through a HDAC6-Pin1 AxisLaura Nogués, Clara Reglero, Verónica Rivas, et al.
Scientific Reports|April 25, 2018
Electrochemical affinity biosensors for fast detection of gene-specific methylations with no need for bisulfite and amplification treatmentsEloy Povedano, Eva Vargas, Víctor Ruiz-Valdepeñas Montiel, et al.
Virchows Archiv : an International Journal of Pathology|August 22, 2021
Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinomaIgnacio Ruz-Caracuel, Álvaro López-Janeiro, Victoria Heredia-Soto, et al.
Plos One|December 20, 2016
3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer PatientsTeodoro Vargas, Juan Moreno-Rubio, Jesús Herranz, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2016
Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine TumorsOmid Fotouhi, Hanna Kjellin, Catharina Larsson, et al.
Biomedicines|February 25, 2023
The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic AdenocarcinomaVictoria Heredia-Soto, Laura Gutiérrez-Sainz, Ismael Ghanem, et al.
Frontiers in Immunology|August 21, 2019
Anti-CXCR4 Antibody Combined With Activated and Expanded Natural Killer Cells for Sarcoma ImmunotherapyMaria Vela, David Bueno, Pablo González-Navarro, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 6, 2023
In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expressionAna Montero-Calle, Álvaro López-Janeiro, Marta L Mendes, et al.
Cancer Cell International|December 5, 2021
Eribulin activity in soft tissue sarcoma monolayer and three-dimensional cell line models: could the combination with other drugs improve its antitumoral effect?Javier Escudero, Victoria Heredia-Soto, Yinyin Wang, et al.
International Journal of Molecular Sciences|September 14, 2024
Cytokines and Pancreatic Ductal Adenocarcinoma: Exploring Their Relationship with Molecular Subtypes and PrognosisLaura Gutierrez-Sainz, Victoria Heredia-Soto, Ana Margarita Rodríguez-García, et al.
Pageof 9